Morgan Stanley
GNTA

Morgan Stanley’s Genenta Science GNTA Stock Holding History

Morgan Stanley’s Portfolio GNTA Stock Details GNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,420
Closed -$10.4K – 8490
2026
Q1 		$10.4K Sell
15,420
-30,480
-66% -$30.9K ﹤0.01% 6933
2025
Q4 		$68.4K Buy
45,900
+43,700
+1,986% +$103K ﹤0.01% 6334
2025
Q3 		$7K Buy
2,200
+200
+10% +$708 ﹤0.01% 7004
2025
Q2 		$6.09K Sell
2,000
-1,400
-41% -$5.46K ﹤0.01% 6983
2025
Q1 		$13.5K Buy
+3,400
New +$13.7K ﹤0.01% 6714
2024
Q4 		– Sell
-500
Closed -$2.13K – 8015
2024
Q3 		$2.13K Hold
500
– – ﹤0.01% 7122
2024
Q2 		$1.55K Hold
500
– – ﹤0.01% 7095
2024
Q1 		$1.75K Hold
500
– – ﹤0.01% 7091
2023
Q4 		$2.48K Hold
500
– – ﹤0.01% 7008
2023
Q3 		$2.58K Hold
500
– – ﹤0.01% 7072
2023
Q2 		$2.95K Hold
500
– – ﹤0.01% 7110
2023
Q1 		$2.9K Hold
500
– – ﹤0.01% 7169
2022
Q4 		$2.75K Hold
500
– – ﹤0.01% 7294
2022
Q3 		$2K Hold
500
– – ﹤0.01% 7468
2022
Q2 		$4K Buy
+500
New +$3.39K ﹤0.01% 7447

Other funds holding GNTA

ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
A
Allianz Munich, Germany $9.48B AUM 23.58% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $2.96B AUM 25.11% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Morgan Stanley's GNTA Position: Q2 2026 in Review

Morgan Stanley sold out of Genenta Science (GNTA) in Q2 2026, closing a stake of 15,420 shares — an estimated $10.4K sold.

Morgan Stanley first reported a position in GNTA in Q2 2022 and held it in 15 quarters. The position peaked at $68.4K in Q4 2025. 9 funds tracked by Wall St. Rank hold GNTA as of Q2 2026.

  • Morgan Stanley reported no remaining Genenta Science position as of Q2 2026 after selling out during the quarter.
  • Morgan Stanley sold 15,420 Genenta Science shares in Q2 2026, an estimated $10.4K.
  • Morgan Stanley first reported a position in Genenta Science in Q2 2022 and held it in 15 quarters.
  • Morgan Stanley's Genenta Science position peaked at $68.4K in Q4 2025.
  • 9 funds tracked by Wall St. Rank held Genenta Science as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.